BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.51
0.00 (0.00%)
At close: May 15, 2026, 4:00 PM EDT
8.40
-0.11 (-1.29%)
After-hours: May 15, 2026, 7:41 PM EDT
BBOT Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$23.88
Upside
+180.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +170.27% | May 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $29 | Strong Buy | Maintains | $27 → $29 | +240.78% | Mar 6, 2026 |
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +170.27% | Feb 11, 2026 |
| Raymond James | Raymond James | Buy Initiates $24 | Buy | Initiates | $24 | +182.02% | Jan 9, 2026 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +193.77% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +135.02% | Dec 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +193.77% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +158.52% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +193.77% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +217.27% | Sep 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +170.27% | Sep 4, 2025 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +193.77% | Aug 18, 2025 |